ALP
Price
$3.17Alerts
Change
+$0.07 (+2.26%)
Updated
Nov 13 closing price
Capitalization
4.65M
9 days until earnings call
Intraday BUY SELL Signals
CORT
Price
$72.94Alerts
Change
-$0.77 (-1.04%)
Updated
Nov 13 closing price
Capitalization
7.87B
106 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ALP vs CORT

ALP vs CORT Comparison Chart in %
View a ticker or compare two or three
VS
ALP vs. CORT commentary
Nov 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALP is a Hold and CORT is a Buy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ALP with price predictions
Nov 13, 2026

ALP's Stochastic Oscillator is sitting in oversold zone for 5 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +5.88% 3-day Advance, the price is estimated to grow further. Considering data from situations where ALP advanced for three days, in 168 of 203 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ALP as a result. In 82 of 88 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

The 50-day moving average for ALP moved below the 200-day moving average on November 12, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ALP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for ALP entered a downward trend on November 02, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 86 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (3.326) is normal, around the industry mean (2.423). P/E Ratio (-0.524) is within average values for comparable stocks, (8.341). Projected Growth (PEG Ratio) (0.360) is also within normal values, averaging (1.318). Dividend Yield (0.000) settles around the average of (0.274) among similar stocks. P/S Ratio (7.752) is also within normal values, averaging (15.906).

The Tickeron Price Growth Rating for this company is 91 (best 1 - 100 worst), indicating slightly worse than average price growth. ALP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ALP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 80, placing this stock worse than average.

A.I.Advisor
a Summary for CORT with price predictions
Nov 13, 2026

CORT's RSI Indicator is staying in oversold zone for 15 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 15 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +4.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where CORT advanced for three days, in 277 of 332 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.

CORT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CORT as a result. In 55 of 85 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 65%.

The Moving Average Convergence Divergence Histogram (MACD) for CORT turned negative on October 14, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 34 similar instances when the indicator turned negative. In 22 of the 34 cases the stock turned lower in the days that followed. This puts the odds of success at 65%.

CORT moved below its 50-day moving average on October 22, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CORT crossed bearishly below the 50-day moving average on October 22, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 6 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 40%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CORT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 64%.

The Aroon Indicator for CORT entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 58 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 64 (best 1 - 100 worst), indicating steady price growth. CORT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 76 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (11.146) is normal, around the industry mean (3.498). CORT's P/E Ratio (137.302) is considerably higher than the industry average of (-1.193). Projected Growth (PEG Ratio) (2.660) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.658) among similar stocks. P/S Ratio (15.898) is also within normal values, averaging (440.869).

FUNDAMENTALS RATINGS
ALP vs CORT: Fundamental Ratings
ALP
CORT
OUTLOOK RATING
1..100
5057
VALUATION
overvalued / fair valued / undervalued
1..100
86
Overvalued
100
Overvalued
PROFIT vs RISK RATING
1..100
10058
SMR RATING
1..100
10076
PRICE GROWTH RATING
1..100
9164
P/E GROWTH RATING
1..100
78
SEASONALITY SCORE
1..100
9050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ALP's Valuation (86) in the null industry is in the same range as CORT (100) in the Pharmaceuticals Other industry. This means that ALP’s stock grew similarly to CORT’s over the last 12 months.

CORT's Profit vs Risk Rating (58) in the Pharmaceuticals Other industry is somewhat better than the same rating for ALP (100) in the null industry. This means that CORT’s stock grew somewhat faster than ALP’s over the last 12 months.

CORT's SMR Rating (76) in the Pharmaceuticals Other industry is in the same range as ALP (100) in the null industry. This means that CORT’s stock grew similarly to ALP’s over the last 12 months.

CORT's Price Growth Rating (64) in the Pharmaceuticals Other industry is in the same range as ALP (91) in the null industry. This means that CORT’s stock grew similarly to ALP’s over the last 12 months.

ALP's P/E Growth Rating (7) in the null industry is in the same range as CORT (8) in the Pharmaceuticals Other industry. This means that ALP’s stock grew similarly to CORT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ALPCORT
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
88%
Bullish Trend 4 days ago
82%
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
65%
MACD
ODDS (%)
N/A
Bearish Trend 4 days ago
65%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
84%
Bullish Trend 4 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
63%
Advances
ODDS (%)
Bullish Trend 6 days ago
83%
Bullish Trend 8 days ago
83%
Declines
ODDS (%)
Bearish Trend 18 days ago
90%
Bearish Trend 4 days ago
64%
BollingerBands
ODDS (%)
N/A
Bullish Trend 4 days ago
86%
Aroon
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
36%
COMPARISON
Comparison
Nov 16, 2026
Stock price -- (ALP: $3.17 vs. CORT: $72.94)
Brand notoriety: ALP and CORT are both not notable
ALP represents the Investment Managers, while CORT is part of the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALP: 48% vs. CORT: 71%
Market capitalization -- ALP: $4.65M vs. CORT: $7.87B
ALP [@Investment Managers] is valued at $4.65M. CORT’s [@Biotechnology] market capitalization is $7.87B. The market cap for tickers in the [@Investment Managers] industry ranges from $1.6 to $182.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Investment Managers] industry is $8.92B. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALP’s FA Score shows that 1 FA rating(s) are green while CORT’s FA Score has 1 green FA rating(s).

  • ALP’s FA Score: 1 green, 4 red.
  • CORT’s FA Score: 1 green, 4 red.
According to our system of comparison, CORT is a better buy in the long-term than ALP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALP’s TA Score shows that 2 TA indicator(s) are bullish while CORT’s TA Score has 4 bullish TA indicator(s).

  • ALP’s TA Score: 2 bullish, 4 bearish.
  • CORT’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, CORT is a better buy in the short-term than ALP.

Price Growth

ALP (@Investment Managers) experienced а +5.67% price change this week, while CORT (@Biotechnology) price change was +0.23% for the same time period.

The average weekly price growth across all stocks in the @Investment Managers industry was -0.51%. For the same industry, the average monthly price growth was -1.44%, and the average quarterly price growth was -3.24%.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.38%. For the same industry, the average monthly price growth was -5.88%, and the average quarterly price growth was -18.27%.

Reported Earning Dates

ALP is expected to report earnings on Nov 25, 2026.

CORT is expected to report earnings on Mar 02, 2027.

Industries' Descriptions

@Investment Managers (-0.51% weekly)

Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.

@Biotechnology (-3.38% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

ALP and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALP has been loosely correlated with BENF. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if ALP jumps, then BENF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALP
1D Price
Change %
ALP100%
+2.26%
BENF - ALP
33%
Loosely correlated
-3.71%
SPRB - ALP
30%
Poorly correlated
+0.98%
CYPH - ALP
29%
Poorly correlated
-3.86%
DYAI - ALP
29%
Poorly correlated
-6.60%
CORT - ALP
29%
Poorly correlated
-1.04%
More

CORT and

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with VTVT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
-1.04%
VTVT - CORT
49%
Loosely correlated
-4.83%
TENX - CORT
41%
Loosely correlated
+0.62%
AGIO - CORT
41%
Loosely correlated
-0.54%
ARCT - CORT
37%
Loosely correlated
-0.95%
AXON - CORT
36%
Loosely correlated
+2.71%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ESGD103.500.18
+0.17%
iShares ESG Aware MSCI EAFE ETF (ESGD)
LVLN24.550.03
+0.12%
State Street SPDR S&P Leveraged Loan ETF (LVLN)
BEEX27.65-0.12
-0.42%
Beehive ETF (BEEX)
QDEC35.59-0.28
-0.78%
FT Vest Nasdaq-100 Buffer ETF - December (QDEC)
QUBX10.79-0.99
-8.39%
Tradr 2X Long QUBT Daily ETF (QUBX)